257 related articles for article (PubMed ID: 35965101)
1. The emerging roles of CFIm25 (NUDT21/CPSF5) in human biology and disease.
Masamha CP
Wiley Interdiscip Rev RNA; 2023; 14(3):e1757. PubMed ID: 35965101
[TBL] [Abstract][Full Text] [Related]
2. CFIm25 and alternative polyadenylation: Conflicting roles in cancer.
Jafari Najaf Abadi MH; Shafabakhsh R; Asemi Z; Mirzaei HR; Sahebnasagh R; Mirzaei H; Hamblin MR
Cancer Lett; 2019 Sep; 459():112-121. PubMed ID: 31181319
[TBL] [Abstract][Full Text] [Related]
3. Nudt21 regulates the alternative polyadenylation of Pak1 and is predictive in the prognosis of glioblastoma patients.
Chu Y; Elrod N; Wang C; Li L; Chen T; Routh A; Xia Z; Li W; Wagner EJ; Ji P
Oncogene; 2019 May; 38(21):4154-4168. PubMed ID: 30705404
[TBL] [Abstract][Full Text] [Related]
4. Suppression of cleavage factor Im 25 promotes the proliferation of lung cancer cells through alternative polyadenylation.
Huang J; Weng T; Ko J; Chen NY; Xiang Y; Volcik K; Han L; Blackburn MR; Lu X
Biochem Biophys Res Commun; 2018 Sep; 503(2):856-862. PubMed ID: 29928883
[TBL] [Abstract][Full Text] [Related]
5. Relationship between NUDT21 mediated alternative polyadenylation process and tumor.
Xiao S; Gu H; Deng L; Yang X; Qiao D; Zhang X; Zhang T; Yu T
Front Oncol; 2023; 13():1052012. PubMed ID: 36816917
[TBL] [Abstract][Full Text] [Related]
6. CFIm25 links alternative polyadenylation to glioblastoma tumour suppression.
Masamha CP; Xia Z; Yang J; Albrecht TR; Li M; Shyu AB; Li W; Wagner EJ
Nature; 2014 Jun; 510(7505):412-6. PubMed ID: 24814343
[TBL] [Abstract][Full Text] [Related]
7. A Cancer-Specific Ubiquitin Ligase Drives mRNA Alternative Polyadenylation by Ubiquitinating the mRNA 3' End Processing Complex.
Yang SW; Li L; Connelly JP; Porter SN; Kodali K; Gan H; Park JM; Tacer KF; Tillman H; Peng J; Pruett-Miller SM; Li W; Potts PR
Mol Cell; 2020 Mar; 77(6):1206-1221.e7. PubMed ID: 31980388
[TBL] [Abstract][Full Text] [Related]
8. NUDT21 negatively regulates PSMB2 and CXXC5 by alternative polyadenylation and contributes to hepatocellular carcinoma suppression.
Tan S; Li H; Zhang W; Shao Y; Liu Y; Guan H; Wu J; Kang Y; Zhao J; Yu Q; Gu Y; Ding K; Zhang M; Qian W; Zhu Y; Cai H; Chen C; Lobie PE; Zhao X; Sun J; Zhu T
Oncogene; 2018 Aug; 37(35):4887-4900. PubMed ID: 29780166
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor β1 alters the 3'-UTR of mRNA to promote lung fibrosis.
Ko J; Mills T; Huang J; Chen NY; Mertens TCJ; Collum SD; Lee G; Xiang Y; Han L; Zhou Y; Lee CG; Elias JA; Jyothula SSK; Rajagopal K; Karmouty-Quintana H; Blackburn MR
J Biol Chem; 2019 Oct; 294(43):15781-15794. PubMed ID: 31488543
[TBL] [Abstract][Full Text] [Related]
10. Partial loss of CFIm25 causes learning deficits and aberrant neuronal alternative polyadenylation.
Alcott CE; Yalamanchili HK; Ji P; van der Heijden ME; Saltzman A; Elrod N; Lin A; Leng M; Bhatt B; Hao S; Wang Q; Saliba A; Tang J; Malovannaya A; Wagner EJ; Liu Z; Zoghbi HY
Elife; 2020 Apr; 9():. PubMed ID: 32319885
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of CFIm25 amplifies dermal fibrosis through alternative polyadenylation.
Weng T; Huang J; Wagner EJ; Ko J; Wu M; Wareing NE; Xiang Y; Chen NY; Ji P; Molina JG; Volcik KA; Han L; Mayes MD; Blackburn MR; Assassi S
J Exp Med; 2020 Feb; 217(2):. PubMed ID: 31757866
[TBL] [Abstract][Full Text] [Related]
12. NUDT21 regulates circRNA cyclization and ceRNA crosstalk in hepatocellular carcinoma.
Li X; Ding J; Wang X; Cheng Z; Zhu Q
Oncogene; 2020 Jan; 39(4):891-904. PubMed ID: 31570791
[TBL] [Abstract][Full Text] [Related]
13. CFIm-mediated alternative polyadenylation safeguards the development of mammalian pre-implantation embryos.
Li N; Cai Y; Zou M; Zhou J; Zhang L; Zhou L; Xiang W; Cui Y; Li H
Stem Cell Reports; 2023 Jan; 18(1):81-96. PubMed ID: 36563685
[TBL] [Abstract][Full Text] [Related]
14. CFIm-mediated alternative polyadenylation remodels cellular signaling and miRNA biogenesis.
Ghosh S; Ataman M; Bak M; Börsch A; Schmidt A; Buczak K; Martin G; Dimitriades B; Herrmann CJ; Kanitz A; Zavolan M
Nucleic Acids Res; 2022 Apr; 50(6):3096-3114. PubMed ID: 35234914
[TBL] [Abstract][Full Text] [Related]
15. RNA Binding Protein CELF2 Regulates Signal-Induced Alternative Polyadenylation by Competing with Enhancers of the Polyadenylation Machinery.
Chatrikhi R; Mallory MJ; Gazzara MR; Agosto LM; Zhu WS; Litterman AJ; Ansel KM; Lynch KW
Cell Rep; 2019 Sep; 28(11):2795-2806.e3. PubMed ID: 31509743
[TBL] [Abstract][Full Text] [Related]
16. NUDT21 regulates 3'-UTR length and microRNA-mediated gene silencing in hepatocellular carcinoma.
Sun M; Ding J; Li D; Yang G; Cheng Z; Zhu Q
Cancer Lett; 2017 Dec; 410():158-168. PubMed ID: 28964783
[TBL] [Abstract][Full Text] [Related]
17. Implications of polyadenylation in health and disease.
Curinha A; Oliveira Braz S; Pereira-Castro I; Cruz A; Moreira A
Nucleus; 2014; 5(6):508-19. PubMed ID: 25484187
[TBL] [Abstract][Full Text] [Related]
18. Cleavage factor 25 deregulation contributes to pulmonary fibrosis through alternative polyadenylation.
Weng T; Ko J; Masamha CP; Xia Z; Xiang Y; Chen NY; Molina JG; Collum S; Mertens TC; Luo F; Philip K; Davies J; Huang J; Wilson C; Thandavarayan RA; Bruckner BA; Jyothula SS; Volcik KA; Li L; Han L; Li W; Assassi S; Karmouty-Quintana H; Wagner EJ; Blackburn MR
J Clin Invest; 2019 May; 129(5):1984-1999. PubMed ID: 30830875
[TBL] [Abstract][Full Text] [Related]
19. NUDT21 inhibits bladder cancer progression through ANXA2 and LIMK2 by alternative polyadenylation.
Xiong M; Chen L; Zhou L; Ding Y; Kazobinka G; Chen Z; Hou T
Theranostics; 2019; 9(24):7156-7167. PubMed ID: 31695759
[No Abstract] [Full Text] [Related]
20. LINC00921 reduces lung cancer radiosensitivity by destabilizing NUDT21 and driving aberrant MED23 alternative polyadenylation.
Zhang N; Liu X; Huang L; Zeng J; Ma C; Han L; Li W; Yu J; Yang M
Cell Rep; 2023 Dec; 42(12):113479. PubMed ID: 37999979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]